Chemours
504 hedge funds and large institutions have $3.95B invested in Chemours in 2021 Q4 according to their latest regulatory filings, with 95 funds opening new positions, 145 increasing their positions, 137 reducing their positions, and 46 closing their positions.
107% more first-time investments, than exits
New positions opened: 95 | Existing positions closed: 46
14% more funds holding in top 10
Funds holding in top 10: 7 → 8 (+1)
11% more capital invested
Capital invested by funds: $3.55B → $3.95B (+$392M)
10% more funds holding
Funds holding: 460 → 504 (+44)
6% more repeat investments, than reductions
Existing positions increased: 145 | Existing positions reduced: 137
1.77% less ownership
Funds ownership: 74.1% → 72.33% (-1.8%)
49% less call options, than puts
Call options by funds: $49.8M | Put options by funds: $98.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$54.1M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$18.3M |
| 3 |
Los Angeles Capital Management
Los Angeles,
California
|
+$16.9M |
| 4 |
Goldman Sachs
New York
|
+$12.7M |
| 5 |
D.E. Shaw & Co
New York
|
+$10.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$64.8M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$34.7M |
| 3 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$33.1M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$22.3M |
| 5 |
SC
Sessa Capital
New York
|
-$21.3M |
CC Hedge Fund Activity: Q4 2021 in Review
504 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q4 2021, worth a combined $3.95B — up 11% from $3.55B a quarter earlier.
Buyers outnumbered sellers: 95 funds opened new CC positions and 46 closed out — a net gain of 49 holders — while 145 added to existing stakes and 137 trimmed.
The largest buyer was Millennium Management, adding an estimated $54.1M. The largest seller was Fidelity Investments, cutting an estimated $64.8M.
- 504 institutional investors held Chemours (CC) as of Q4 2021, up from 460 in Q3 2021.
- Funds reported $3.95B of Chemours stock for Q4 2021, up 11% quarter-over-quarter.
- 95 funds opened new Chemours positions in Q4 2021 and 46 closed out, a net change of +49 holders.
- The largest Chemours buyer in Q4 2021 was Millennium Management, an estimated $54.1M added.
- The largest Chemours seller in Q4 2021 was Fidelity Investments, an estimated $64.8M sold.
Based on aggregated 13F filings for Q4 2021.